Cargando…
Young children with multidrug-resistant epilepsy and vagus nerve stimulation responding to perampanel: A case report
BACKGROUND: Perampanel (PER), a third-generation antiepileptic drug, is a selective and noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, and has been approved for the treatment of adults and adolescents with focal epilepsy. However, there are only a few studie...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048547/ https://www.ncbi.nlm.nih.gov/pubmed/35611206 http://dx.doi.org/10.12998/wjcc.v10.i11.3511 |